Skip to content

APOTHEEK MEEUSEN

Active
Private limited companyfounded 2001active for 25 yearsOostmalseweg 102 A, 2340 Beerse, BelgiumKBO/BCE: BE 0475.582.387
Summary

APOTHEEK MEEUSEN has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €734,993 and a net result of €126,369. Equity has been growing by about 12% per year since 2018. Its solvency ranks better than 60% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

Source: KBO
Status
Active since 19-09-2001 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730and 1 other
Establishment unit
2.131.486.215 2340 Beerse, since 05-10-2001
Financial year end
31 December
Peppol
Reachable since 28-12-2024

Board and ownership

Last known board
  • GOMEDirector · until 2023
Shareholders
  • GOME· score 912025 annual accounts of GOME

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€435,522
▲ 1.6%
Turnover
≈ €1.6m
estimated
Profit
€126,369
▼ 0.8%
Equity
€734,993
▲ 19.5%
Total assets
€1.6m
▲ 3.7%
Employees on 31-12-2025
5
▲ 25.0%
Filed on 29-05-2026, 63 days before the deadline
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskFounded in 2001Size: 2.2 FTE, total assets €1.6mEquity €734,993 (46.1% of total assets)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 62% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 71+6
equity 46.1% of total assets
Liquidity 48+1
short-term debt 25.6% · cash 6.0%
Profitability 79=
return on assets 7.9%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.2% 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025highest value 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026lowest value 08-2026: 0.2%● unchanged vs 07-2026lowest value 09-2026: 0.2%● unchanged vs 08-2026lowest value 10-2026: 0.2%● unchanged vs 09-2026lowest value 11-2026: 0.2%● unchanged vs 10-2026lowest value
Credit of up to €65,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.54 (1.37 in 2024), above the usual 1.5. Short-term debt is 25.6% and cash 6% of total assets. However, 53.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 61% of them on solvency, 48% on liquidity, 69% on profitability and 72% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 2001
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Size: 2.2 FTE, total assets €1.6m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €734,993 (46.1% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-05-2026, 63 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
63 days early
2024
93 days early
2023
98 days early
2022
56 days early
2021
59 days early
2020
on the day
2019
20 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 50 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 May (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 80% of companies in retail tradesector median €236,771 · 12,767 companies €734,993 View
  • Positive: 7 profitable years in a rowprofit 2025: €126,369 7 years View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View

Recent changes

  1. · Gazette deed Resignation: Gome (director)Permanent representative: MEEUSEN Kim
  2. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as APOTHEEK MEEUSEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.3m and €1.7m, founded between 1999 and 2002.

CompanyTotal assetsGross margin
APOTHEEK MEEUSEN Beerse€1.6m€0.4m
APOTHEEK VAN DEN DWEY H. Antwerpen€1.6m€0.4m
Apotheekcentra Koksijde€1.7m€0.4m
APOTHEEK ZAGHBOUR Antwerpen€1.6m€0.5m
BORNEM PHARMA Bornem€1.3m€0.5m
APOTHEEK BAUWENS DONALD Sint-Niklaas€1.7m€0.4m
PHARMACIE CARRA Seraing€1.4m€0.4m
Full comparison

Key facts about APOTHEEK MEEUSEN

What is the company number of APOTHEEK MEEUSEN?
The company number of APOTHEEK MEEUSEN is 0475.582.387. The VAT number is the same number with BE in front: BE 0475.582.387.
Where is APOTHEEK MEEUSEN based?
The registered office is at Oostmalseweg 102 A, 2340 Beerse.Company details
What does APOTHEEK MEEUSEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK MEEUSEN?
The legal form of APOTHEEK MEEUSEN is Private limited company (BV).
When was APOTHEEK MEEUSEN founded?
APOTHEEK MEEUSEN was founded on 19-09-2001.
Is APOTHEEK MEEUSEN still active?
Yes, APOTHEEK MEEUSEN is an active enterprise in the KBO register.
How many employees does APOTHEEK MEEUSEN have?
APOTHEEK MEEUSEN had an average of 2.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK MEEUSEN?
The turnover in financial year 2025 is ≈ €1.6m. This figure is estimated from the gross margin of €435,522 and 47 comparable companies (NACE 477). It probably lies between €1.2m and €2.6m.
Is APOTHEEK MEEUSEN profitable?
In financial year 2025, APOTHEEK MEEUSEN made a profit of €126,369.
Where can I find the annual accounts of APOTHEEK MEEUSEN?
APOTHEEK MEEUSEN filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK MEEUSEN due?
APOTHEEK MEEUSEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.